patient_id,note_date,index_date,eligible_label,ineligible_reasons,age,sex,race_ethnicity,height_cm,weight_kg,bmi,smoking_status,alcohol_use,outpatient_visits_last_12m,diagnoses,medications,allergies,pregnancy_status,recent_cardiovascular_event_6m,systemic_steroids_chronic,active_malignancy_systemic_tx_12m,narrative_note
P0007,2025-11-19,2025-11-29,INELIGIBLE,Age outside inclusion range (79 years),79,Female,Middle Eastern,163,132,49.7,Current,Social,1,Type 2 diabetes mellitus; Hyperlipidemia; Obesity,Metformin 500 mg BID (patient reports intolerance to higher dose); Losartan 50 mg daily,Sulfa drugs (hives),Not pregnant,No,No,No,79-year-old Female with a history of type 2 diabetes diagnosed 7 years ago. Seen for routine outpatient follow-up. Reports mild fatigue. Current therapy: Metformin 500 mg BID (patient reports intolerance to higher dose); Losartan 50 mg daily. Home glucose readings: fasting 120–160 mg/dL. Comorbidities: dyslipidemia; obesity. Denies hypoglycemia requiring assistance. Last HbA1c on 2025-11-29 was 8.1%. Plan: optimize regimen and follow-up in 8–12 weeks. Not eligible for cohort due to: Age outside inclusion range (79 years).
